Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.
Di Bonito P, Grasso F, Mochi S, Accardi L, Donà MG, Branca M, Costa S, Mariani L, Agarossi A, Ciotti M, Syrjänen K, Giorgi C. Di Bonito P, et al. Among authors: branca m. Infect Agent Cancer. 2006 Nov 8;1:6. doi: 10.1186/1750-9378-1-6. Infect Agent Cancer. 2006. PMID: 17150135 Free PMC article.
Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.
Giorgi C, Di Bonito P, Grasso F, Mochi S, Accardi L, Donà MG, Branca M, Costa S, Mariani L, Agarossi A, Ciotti M, Syrjänen K; HPV-PathogenISS group. Giorgi C, et al. Among authors: branca m. Infect Agent Cancer. 2008 Jun 26;3:9. doi: 10.1186/1750-9378-3-9. Infect Agent Cancer. 2008. PMID: 18582363 Free PMC article.
Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
Branca M, Ciotti M, Santini D, Bonito LD, Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K; HPV-Pathogen ISS Study Group. Branca M, et al. Am J Clin Pathol. 2004 Dec;122(6):902-11. doi: 10.1309/VQXF-T880-JXC7-QD2W. Am J Clin Pathol. 2004. PMID: 15539382
Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen SM, Favalli C, Syrjänen K; HPV-PathogenISS Study Group. Branca M, et al. Int J Gynecol Pathol. 2006 Oct;25(4):383-92. doi: 10.1097/01.pgp.0000209573.54457.32. Int J Gynecol Pathol. 2006. PMID: 16990717
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group. Branca M, et al. Int J Gynecol Pathol. 2008 Apr;27(2):265-73. doi: 10.1097/PGP.0b013e318159cbc0. Int J Gynecol Pathol. 2008. PMID: 18317213
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Costa S, Benedetto A, Casolati EA, Favalli C, Paba P, Di Bonito P, Mariani L, Syrjänen S, Bonifacio D, Accardi L, Zanconati F, Syrjänen K; HPV-Pathogen ISS Study Group. Branca M, et al. Am J Clin Pathol. 2005 Jul;124(1):113-21. doi: 10.1309/L8BWF431WU9AC8FJ. Am J Clin Pathol. 2005. PMID: 15923164
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group. Branca M, et al. Acta Cytol. 2006 Jan-Feb;50(1):6-15. doi: 10.1159/000325887. Acta Cytol. 2006. PMID: 16514834
Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Costa S, Syrjänen K. Syrjänen S, et al. Among authors: branca m. Virchows Arch. 2009 Dec;455(6):505-15. doi: 10.1007/s00428-009-0850-7. Epub 2009 Nov 12. Virchows Arch. 2009. PMID: 19908064
p300 expression is related to high-risk human papillomavirus infections and severity of cervical intraepithelial neoplasia but not to viral or disease outcomes in a longitudinal setting.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Arlindo F, Sakamoto-Maeda M, Costa S, Syrjänen K. Syrjänen S, et al. Among authors: branca m. Int J Gynecol Pathol. 2010 Mar;29(2):135-45. doi: 10.1097/PGP.0b013e3181bccaec. Int J Gynecol Pathol. 2010. PMID: 20173499
275 results